Decreased Expression of Placental Proteins in Recurrent Pregnancy Loss: Functional Relevance and Diagnostic Value

Miscarriages affect 50–70% of all conceptions and 15–20% of clinically recognized pregnancies. Recurrent pregnancy loss (RPL, ≥2 miscarriages) affects 1–5% of recognized pregnancies. Nevertheless, our knowledge about the etiologies and pathophysiology of RPL is incomplete, and thus, reliable diagnos...

Full description

Bibliographic Details
Main Authors: Eszter Tóth, Dániel Györffy, Máté Posta, Petronella Hupuczi, Andrea Balogh, Gábor Szalai, Gergő Orosz, László Orosz, András Szilágyi, Orsolya Oravecz, Lajos Veress, Sándor Nagy, Olga Török, Padma Murthi, Offer Erez, Zoltán Papp, Nándor Ács, Nándor Gábor Than
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/25/3/1865
_version_ 1797318630736658432
author Eszter Tóth
Dániel Györffy
Máté Posta
Petronella Hupuczi
Andrea Balogh
Gábor Szalai
Gergő Orosz
László Orosz
András Szilágyi
Orsolya Oravecz
Lajos Veress
Sándor Nagy
Olga Török
Padma Murthi
Offer Erez
Zoltán Papp
Nándor Ács
Nándor Gábor Than
author_facet Eszter Tóth
Dániel Györffy
Máté Posta
Petronella Hupuczi
Andrea Balogh
Gábor Szalai
Gergő Orosz
László Orosz
András Szilágyi
Orsolya Oravecz
Lajos Veress
Sándor Nagy
Olga Török
Padma Murthi
Offer Erez
Zoltán Papp
Nándor Ács
Nándor Gábor Than
author_sort Eszter Tóth
collection DOAJ
description Miscarriages affect 50–70% of all conceptions and 15–20% of clinically recognized pregnancies. Recurrent pregnancy loss (RPL, ≥2 miscarriages) affects 1–5% of recognized pregnancies. Nevertheless, our knowledge about the etiologies and pathophysiology of RPL is incomplete, and thus, reliable diagnostic/preventive tools are not yet available. Here, we aimed to define the diagnostic value of three placental proteins for RPL: human chorionic gonadotropin free beta-subunit (free-β-hCG), pregnancy-associated plasma protein-A (PAPP-A), and placental growth factor (PlGF). Blood samples were collected from women with RPL (<i>n</i> = 14) and controls undergoing elective termination of pregnancy (<i>n</i> = 30) at the time of surgery. Maternal serum protein concentrations were measured by BRAHMS KRYPTOR Analyzer. Daily multiple of median (dMoM) values were calculated for gestational age-specific normalization. To obtain classifiers, logistic regression analysis was performed, and ROC curves were calculated. There were differences in changes of maternal serum protein concentrations with advancing healthy gestation. Between 6 and 13 weeks, women with RPL had lower concentrations and dMoMs of free β-hCG, PAPP-A, and PlGF than controls. PAPP-A dMoM had the best discriminative properties (AUC = 0.880). Between 9 and 13 weeks, discriminative properties of all protein dMoMs were excellent (free β-hCG: AUC = 0.975; PAPP-A: AUC = 0.998; PlGF: AUC = 0.924). In conclusion, free-β-hCG and PAPP-A are valuable biomarkers for RPL, especially between 9 and 13 weeks. Their decreased concentrations indicate the deterioration of placental functions, while lower PlGF levels indicate problems with placental angiogenesis after 9 weeks.
first_indexed 2024-03-08T03:55:08Z
format Article
id doaj.art-ebd255c6287041f6812632da19299957
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-08T03:55:08Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-ebd255c6287041f6812632da192999572024-02-09T15:14:55ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672024-02-01253186510.3390/ijms25031865Decreased Expression of Placental Proteins in Recurrent Pregnancy Loss: Functional Relevance and Diagnostic ValueEszter Tóth0Dániel Györffy1Máté Posta2Petronella Hupuczi3Andrea Balogh4Gábor Szalai5Gergő Orosz6László Orosz7András Szilágyi8Orsolya Oravecz9Lajos Veress10Sándor Nagy11Olga Török12Padma Murthi13Offer Erez14Zoltán Papp15Nándor Ács16Nándor Gábor Than17Systems Biology of Reproduction Research Group, Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Magyar Tudósok Körútja 2, H-1117 Budapest, HungarySystems Biology of Reproduction Research Group, Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Magyar Tudósok Körútja 2, H-1117 Budapest, HungarySystems Biology of Reproduction Research Group, Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Magyar Tudósok Körútja 2, H-1117 Budapest, HungaryMaternity Private Clinic of Obstetrics and Gynecology, H-1126 Budapest, HungarySystems Biology of Reproduction Research Group, Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Magyar Tudósok Körútja 2, H-1117 Budapest, HungarySystems Biology of Reproduction Research Group, Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Magyar Tudósok Körútja 2, H-1117 Budapest, HungaryDepartment of Obstetrics and Gynecology, Medical School, University of Debrecen, H-4032 Debrecen, HungaryDepartment of Obstetrics and Gynecology, Medical School, University of Debrecen, H-4032 Debrecen, HungarySystems Biology of Reproduction Research Group, Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Magyar Tudósok Körútja 2, H-1117 Budapest, HungarySystems Biology of Reproduction Research Group, Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Magyar Tudósok Körútja 2, H-1117 Budapest, HungaryDepartment of Pharmacology and Pharmacotherapy, Medical School, University of Debrecen, H-4032 Debrecen, HungaryFaculty of Health and Sport Sciences, Széchenyi István University, H-9026 Győr, HungaryDepartment of Obstetrics and Gynecology, Medical School, University of Debrecen, H-4032 Debrecen, HungaryDepartment of Pharmacology, Monash Biomedicine Discovery Institute, Clayton 3168, AustraliaDepartment of Obstetrics and Gynecology, Soroka University Medical Center, Ben Gurion University of the Negev, Be’er Sheva 8410501, IsraelMaternity Private Clinic of Obstetrics and Gynecology, H-1126 Budapest, HungaryDepartment of Obstetrics and Gynecology, Medical School, Semmelweis University, 27 Baross Street, H-1088 Budapest, HungarySystems Biology of Reproduction Research Group, Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Magyar Tudósok Körútja 2, H-1117 Budapest, HungaryMiscarriages affect 50–70% of all conceptions and 15–20% of clinically recognized pregnancies. Recurrent pregnancy loss (RPL, ≥2 miscarriages) affects 1–5% of recognized pregnancies. Nevertheless, our knowledge about the etiologies and pathophysiology of RPL is incomplete, and thus, reliable diagnostic/preventive tools are not yet available. Here, we aimed to define the diagnostic value of three placental proteins for RPL: human chorionic gonadotropin free beta-subunit (free-β-hCG), pregnancy-associated plasma protein-A (PAPP-A), and placental growth factor (PlGF). Blood samples were collected from women with RPL (<i>n</i> = 14) and controls undergoing elective termination of pregnancy (<i>n</i> = 30) at the time of surgery. Maternal serum protein concentrations were measured by BRAHMS KRYPTOR Analyzer. Daily multiple of median (dMoM) values were calculated for gestational age-specific normalization. To obtain classifiers, logistic regression analysis was performed, and ROC curves were calculated. There were differences in changes of maternal serum protein concentrations with advancing healthy gestation. Between 6 and 13 weeks, women with RPL had lower concentrations and dMoMs of free β-hCG, PAPP-A, and PlGF than controls. PAPP-A dMoM had the best discriminative properties (AUC = 0.880). Between 9 and 13 weeks, discriminative properties of all protein dMoMs were excellent (free β-hCG: AUC = 0.975; PAPP-A: AUC = 0.998; PlGF: AUC = 0.924). In conclusion, free-β-hCG and PAPP-A are valuable biomarkers for RPL, especially between 9 and 13 weeks. Their decreased concentrations indicate the deterioration of placental functions, while lower PlGF levels indicate problems with placental angiogenesis after 9 weeks.https://www.mdpi.com/1422-0067/25/3/1865bioinformaticshabitual abortionliquid biopsynon-invasive monitoringplacental proteinprenatal diagnostics
spellingShingle Eszter Tóth
Dániel Györffy
Máté Posta
Petronella Hupuczi
Andrea Balogh
Gábor Szalai
Gergő Orosz
László Orosz
András Szilágyi
Orsolya Oravecz
Lajos Veress
Sándor Nagy
Olga Török
Padma Murthi
Offer Erez
Zoltán Papp
Nándor Ács
Nándor Gábor Than
Decreased Expression of Placental Proteins in Recurrent Pregnancy Loss: Functional Relevance and Diagnostic Value
International Journal of Molecular Sciences
bioinformatics
habitual abortion
liquid biopsy
non-invasive monitoring
placental protein
prenatal diagnostics
title Decreased Expression of Placental Proteins in Recurrent Pregnancy Loss: Functional Relevance and Diagnostic Value
title_full Decreased Expression of Placental Proteins in Recurrent Pregnancy Loss: Functional Relevance and Diagnostic Value
title_fullStr Decreased Expression of Placental Proteins in Recurrent Pregnancy Loss: Functional Relevance and Diagnostic Value
title_full_unstemmed Decreased Expression of Placental Proteins in Recurrent Pregnancy Loss: Functional Relevance and Diagnostic Value
title_short Decreased Expression of Placental Proteins in Recurrent Pregnancy Loss: Functional Relevance and Diagnostic Value
title_sort decreased expression of placental proteins in recurrent pregnancy loss functional relevance and diagnostic value
topic bioinformatics
habitual abortion
liquid biopsy
non-invasive monitoring
placental protein
prenatal diagnostics
url https://www.mdpi.com/1422-0067/25/3/1865
work_keys_str_mv AT esztertoth decreasedexpressionofplacentalproteinsinrecurrentpregnancylossfunctionalrelevanceanddiagnosticvalue
AT danielgyorffy decreasedexpressionofplacentalproteinsinrecurrentpregnancylossfunctionalrelevanceanddiagnosticvalue
AT mateposta decreasedexpressionofplacentalproteinsinrecurrentpregnancylossfunctionalrelevanceanddiagnosticvalue
AT petronellahupuczi decreasedexpressionofplacentalproteinsinrecurrentpregnancylossfunctionalrelevanceanddiagnosticvalue
AT andreabalogh decreasedexpressionofplacentalproteinsinrecurrentpregnancylossfunctionalrelevanceanddiagnosticvalue
AT gaborszalai decreasedexpressionofplacentalproteinsinrecurrentpregnancylossfunctionalrelevanceanddiagnosticvalue
AT gergoorosz decreasedexpressionofplacentalproteinsinrecurrentpregnancylossfunctionalrelevanceanddiagnosticvalue
AT laszloorosz decreasedexpressionofplacentalproteinsinrecurrentpregnancylossfunctionalrelevanceanddiagnosticvalue
AT andrasszilagyi decreasedexpressionofplacentalproteinsinrecurrentpregnancylossfunctionalrelevanceanddiagnosticvalue
AT orsolyaoravecz decreasedexpressionofplacentalproteinsinrecurrentpregnancylossfunctionalrelevanceanddiagnosticvalue
AT lajosveress decreasedexpressionofplacentalproteinsinrecurrentpregnancylossfunctionalrelevanceanddiagnosticvalue
AT sandornagy decreasedexpressionofplacentalproteinsinrecurrentpregnancylossfunctionalrelevanceanddiagnosticvalue
AT olgatorok decreasedexpressionofplacentalproteinsinrecurrentpregnancylossfunctionalrelevanceanddiagnosticvalue
AT padmamurthi decreasedexpressionofplacentalproteinsinrecurrentpregnancylossfunctionalrelevanceanddiagnosticvalue
AT offererez decreasedexpressionofplacentalproteinsinrecurrentpregnancylossfunctionalrelevanceanddiagnosticvalue
AT zoltanpapp decreasedexpressionofplacentalproteinsinrecurrentpregnancylossfunctionalrelevanceanddiagnosticvalue
AT nandoracs decreasedexpressionofplacentalproteinsinrecurrentpregnancylossfunctionalrelevanceanddiagnosticvalue
AT nandorgaborthan decreasedexpressionofplacentalproteinsinrecurrentpregnancylossfunctionalrelevanceanddiagnosticvalue